Dual-Target Antibody Strikes Two Inflammatory Pathways to Ease Colitis in Mice
Scientists have engineered a bispecific antibody that simultaneously blocks TL1A and IL-12/23p40, suppressing pathogenic Th1/Th17 immune responses and significantly ameliorating ...
